Intellectual Property Magazine
Visus Therapeutics appoints vice president of IP
Clinical-stage pharmaceutical company Visus Therapeutics Inc has appointed Bristol Myers Squibb senior counsel Alex Oh as
vice president of intellectual property (IP).